Stable angina pectoris complex therapy – influence on the main pathogenesis links.

Abstract

Prevention of stable angina destabilization is the main goal of finding an effective drug correction. Uric acid is emerging as one of the cardiovascular risk markers, which has been shown to be associated with adverse cardiovascular events, especially in patients with high cardiovascular risk. According to the recommendations, stable coronary heart disease pharmacological treatment, in addition to traditional first- and second-line drugs, is supplemented with allopurinol. The aim of the study. To study the features of the functional state of the myocardium when allopurinol and quercetin are included in the stable angina pectoris complex therapy.